Cargando…
Prevalence of adverse events during ticagrelor versus clopidogrel treatment and its association with premature discontinuation of dual antiplatelet therapy in East Asian patients with acute coronary syndrome
BACKGROUND: Clinical evidence raises the issues regarding the high risk of adverse events and serious bleeding in East Asian patients receiving standard-dose ticagrelor treatment. We sought to evaluate the association between adverse events and their associations with premature discontinuation of du...
Autores principales: | Kang, Min Gyu, Ahn, Jong Hwa, Kim, Kyehwan, Koh, Jin-Sin, Park, Joeng Rang, Hwang, Seok Jae, Park, Yongwhi, Tantry, Udaya S., Gurbel, Paul A., Hwang, Jin-Yong, Jeong, Young-Hoon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9791044/ https://www.ncbi.nlm.nih.gov/pubmed/36578832 http://dx.doi.org/10.3389/fcvm.2022.1053867 |
Ejemplares similares
-
Pharmacodynamic Effect of Cilostazol Plus Standard Clopidogrel Versus Double-Dose Clopidogrel in Patients With Type 2 Diabetes Undergoing Percutaneous Coronary Intervention
por: Jeong, Young-Hoon, et al.
Publicado: (2012) -
Residual Inflammatory Risk and its Association With Events in East Asian Patients After Coronary Intervention
por: Ahn, Jong-Hwa, et al.
Publicado: (2022) -
Association Between Thrombogenicity Indices and Coronary Microvascular Dysfunction in Patients With Acute Myocardial Infarction
por: Kang, Min Gyu, et al.
Publicado: (2021) -
Personalized antiplatelet therapy: state of the art
por: Gurbel, Paul A, et al.
Publicado: (2012) -
State of the art: Oral antiplatelet therapy
por: Gurbel, Paul A, et al.
Publicado: (2016)